Beacon Capital Management LLC (Tennessee)’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BDTX
DIM
PFSRSONJ
DT
JSSH
BCM
KCM
CUAMC
SCM
Beacon Capital Management LLC (Tennessee)'s BDTX Position: Q2 2026 in Review
Beacon Capital Management LLC (Tennessee) held its Black Diamond Therapeutics (BDTX) position steady in Q2 2026 at 15,615 shares worth $28.9K. The position accounts for ﹤0.01% of the portfolio, ranked #175.
Beacon Capital Management LLC (Tennessee) first reported a position in BDTX in Q1 2022 and has held it in 18 quarters since. The position peaked at $88K in Q3 2022. 13 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.
- Beacon Capital Management LLC (Tennessee) held 15,615 shares of Black Diamond Therapeutics worth $28.9K as of Q2 2026.
- Beacon Capital Management LLC (Tennessee) left its Black Diamond Therapeutics share count unchanged in Q2 2026.
- Black Diamond Therapeutics made up ﹤0.01% of Beacon Capital Management LLC (Tennessee)'s portfolio in Q2 2026, its #175 holding.
- Beacon Capital Management LLC (Tennessee) first reported a position in Black Diamond Therapeutics in Q1 2022 and has held it in 18 quarters since.
- Beacon Capital Management LLC (Tennessee)'s Black Diamond Therapeutics position peaked at $88K in Q3 2022.
- 13 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.
Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q2 2026, filed 29 Jul 2026.